相关实验视频
Updated: May 9, 2025

05:17
Intravenous Injections in Neonatal Mice
Published on: November 11, 2014
58.1K
一种基于生理学的建模方法,用于评估术后和早产新生儿的静脉莱维他剂量
Alexis Johnson1, Nolan Thomas1, Max Blumenthal1
1Pharmacy Practice and Translational Research Division, School of Pharmacy, University of Wisconsin-Madison, Madison, USA.
Journal of clinical pharmacology
|May 2, 2025
概括
关于新生儿发作时使用 levetiracetam 剂量的新研究表明,目前的治疗方案可能对早产婴儿来说过高. 这项研究开发了一个模型来优化 levetiracetam 剂量,降低脆弱新生儿不良事件或不充分影响的风险.
科学领域:
- 新生儿神经病学 新生儿神经病学
- 药理动力学 药理动力学
- 药物开发 药物开发
背景情况:
- 新生儿发作很常见,而芬诺巴比塔尔会引起不良影响.
- 莱维他是一种更安全的替代品,但最佳的新生儿剂量是未知的.
- 目前基于体重的剂量可能不适合早产新生儿.
研究的目的:
- 开发一种基于生理学上的药理动力学 (PBPK) 模型,用于期中和早产新生儿的 levetiracetam.
- 为了评估期满和早产新生儿之间的药理动力学差异.
- 为了告知最佳的 levetiracetam 剂量策略用于新生儿发作.
主要方法:
- 在新生儿中开发了一种PBPK模型用于 levetiracetam.
- 考虑了影响药物分发和清除的生理变化.
- 额外推算和代谢清除,使用全米缩放和年龄依赖的校正.
主要成果:
- 新生儿的组织分布需要增加1.56倍.
- 脏清除需要61%的新生儿增加.
- 在早产新生儿 (<37.5周),清除是主要的排泄途径,代谢清除接近零.
- 模拟表明,在更多早产新生儿中,血度较高,可能超过毒性值.
结论:
- 标准的 levetiracetam 剂量可能导致早产新生儿的毒性.
- 对于早产婴儿来说,可能需要基于体重的较低剂量.
- PBPK建模对于理解和优化新生儿药物剂量至关重要.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
180
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
180
Factors Affecting Drug Response: Overview
1.6K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.6K
Pharmacokinetic Models: Comparison and Selection Criterion
20
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
20
One-Compartment Model: IV Infusion
117
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
117
One-Compartment Open Model for IV Bolus Administration: General Considerations
112
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
112
Two-Compartment Open Model: IV Bolus Administration
231
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
The disparity between drug input and the sum of drug transfer rates between...
231

